Equity
€27,621 ▼ 43.2%
Docteur Benoît DEWART paid out €52,900 in dividends. That is 166% of the 2025 profit.
Docteur Benoît DEWART
Lifetime
6 annual accounts with figures on one time axispeak €51,817 (2025)
€51,817▲ 10.4%
peak €31,877 (2025)
€31,877▲ 35.8%
peak €48,694 (2023)
€27,621▼ 43.2%
€98,338▲ 40.7%
Board1 name since 2021
1 directorDEWART BENOIT
Documentsfilings and deeds
20-07-202611 days before the deadline
2025micro format
Result from €23,480 to €31,877Dividend €52,900Equity from €48,644 to €27,621Debts from €69,898 to €98,338Cash from €17,177 to €29,390
Key points
from the 2025 annual accountsChecked score
91
Excellent
Financially stronger than 32% of micro companies in human health (NACE 86)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: < 0.1% across 24,180 companies (NACE 86, micro).
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: 0.1%
01-2025: 0.1%● unchanged vs 12-2024
02-2025: 0.1%● unchanged vs 01-2025
03-2025: 0.1%● unchanged vs 02-2025
04-2025: 0.1%● unchanged vs 03-2025
05-2025: 0.2%▲ +0.1 percentage points vs 04-2025
06-2025: 0.2%● unchanged vs 05-2025
07-2025: 0.2%● unchanged vs 06-2025
08-2025: 0.4%▲ +0.2 percentage points vs 07-2025
09-2025: 0.6%▲ +0.2 percentage points vs 08-2025
10-2025: 0.5%▼ -0.1 percentage points vs 09-2025
11-2025: 0.5%● unchanged vs 10-2025
12-2025: 0.5%● unchanged vs 11-2025
01-2026: 0.5%● unchanged vs 12-2025
02-2026: 0.5%● unchanged vs 01-2026
03-2026: 0.7%▲ +0.2 percentage points vs 02-2026
04-2026: 0.6%▼ -0.1 percentage points vs 03-2026
05-2026: 0.6%● unchanged vs 04-2026
06-2026: 0.6%● unchanged vs 05-2026
07-2026: 0.7%▲ +0.1 percentage points vs 06-2026highest value
08-2026: 0.2%▼ -0.5 percentage points vs 07-2026
09-2026: 0.2%● unchanged vs 08-2026
10-2026: 0.1%▼ -0.1 percentage points vs 09-2026lowest value
11-2026: 0.1%● unchanged vs 10-2026lowest value
Financial strengthAverage
Score breakdown
raises risk
No registered site in the KBO
lowers risk
Sector: Human health activities (NACE 86)
Liquidity: current ratio 1.00, cash €29,390
Size: total assets €125,959
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 21% of them on solvency, 11% on liquidity, 80% on profitability and 14% on growth.
The bankruptcy probability was computed on 06-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 6,713 companies had the same profile as Docteur Benoît DEWART has now. Each dot stands for 17 companies, two years later.
95.8%
were still trading
2.2%
stopped another way
1.8%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
The bankruptcy probability of Docteur Benoît DEWART itself is lower: 0.1% within 12 months. It rests on far more data about Docteur Benoît DEWART than the profile alone.
Test of the method
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 6,713 companies, not a prediction for Docteur Benoît DEWART. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €2,500 on 30-day terms is acceptable
Liquidity is tight, with a current ratio of 1.0 (1.54 in 2024), below the usual 1.5. Short-term debt is 69.4% and cash 23.3% of total assets. 78.1% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Six signals.
lowers riskraises riskneutral
raises risk · Weak solvency compared with the sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 21% of 20749 sector peers (2025).
NBB · sector comparisonPosition among 20749 sector peers
Solvency
better than 21%
← weakest
strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 20-07-2026, 11 days ahead of the deadline.
NBB · 6 filingsDeviation from the deadline
2025
11 days early
2024
57 days late
2023
30 days late
2022
25 days late
2021
26 days early
2020
31 days late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 6 accounts on average 18 days after the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 25 August (4 of the last 5 accounts filed within 36 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
07-11-2026 today31-12-2026 year end31-07-2027 deadline
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0746663933
Registered office moved from Liège to Namur
New registered office: Rue Villana 11, 5100 Namur · Previous registered office: rue Lairesse 60, 4020 Liège · General meeting of 01-07-2024 · Gazette deed
Incorporation
published on 06-05-2020 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| Docteur Benoît DEWART Namur | €125,959 | €51,817 | 21.9% | - |
| Dokter Abigail Lafaille Kontich | €124,722 | €52,565 | 25.5% | - |
| Société d'Assistance Médicale Rixensart | €121,077 | €52,255 | 74.5% | - |
| DR. ANNE SCHUERMANS Genk | €117,678 | €52,555 | 25.9% | - |
| HEALTHCARE CLINIC Anderlecht | €135,341 | €49,514 | 31.2% | - |
| Dr. Sophie Van Steenbergen - Huisarts Boechout | €125,121 | €46,987 | 12.0% | - |
| SYKLI - HUISARTS Bekkevoort | €107,643 | €49,119 | 1.4% | - |
These companies have the same main activity as Docteur Benoît DEWART: general medical practice (NACE 86210). They are comparable in size and age: total assets between €108,000 and €135,000, founded between 2019 and 2020.
Official details
Source: KBO- Status
- Active since 04-05-2020Normal situation
- Activity
- General medical practiceNACE 86210
- Financial year end
- 31 December
- Peppol
- Reachable since 08-12-2025
Annual accounts 2025
- ≈ €120,000estimated
- €125,959▲ 6.3%
- Filing
- Filed on 20-07-2026, 11 days before the end of the filing period
Insights on Docteur Benoît DEWART
Docteur Benoît DEWART files the micro format. That format states no turnover. The gross margin rose from €20,735 in 2020 to €51,817 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about Docteur Benoît DEWART
- What is the company number of Docteur Benoît DEWART?
- The company number of Docteur Benoît DEWART is 0746.663.933. The VAT number is the same number with BE in front: BE 0746.663.933.
- Where is Docteur Benoît DEWART based?
- The registered office is at Rue Villana 11, 5100 Namur.Company details
- What does Docteur Benoît DEWART do?
- According to the KBO register, the main activity is general medical practice (NACE 86210).
- What is the legal form of Docteur Benoît DEWART?
- Docteur Benoît DEWART is a private limited company (BV).
- When was Docteur Benoît DEWART founded?
- Docteur Benoît DEWART was founded on 04-05-2020.
- Is Docteur Benoît DEWART still active?
- Yes, Docteur Benoît DEWART is an active enterprise in the KBO register.
- What is the turnover of Docteur Benoît DEWART?
- The turnover in financial year 2025 is ≈ €120,000. This figure is estimated from the gross margin of €51,817 and 32 comparable companies (NACE 862). It probably lies between €90,000 and €150,000.Financials
- Is Docteur Benoît DEWART profitable?
- In financial year 2025, Docteur Benoît DEWART made a profit of €31,877.
- Where can I find the annual accounts of Docteur Benoît DEWART?
- Docteur Benoît DEWART filed 6 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of Docteur Benoît DEWART due?
- Docteur Benoît DEWART must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.